Advances in Psilocybin Research
Join us for an extended webinar focusing on the recent advances in psilocybin research.
Rapid Leukemia Classification Using Nanopore Sequencing
Our major findings were that the neural network was able to accurately classify 11 out of 12 leukemia samples, with as little as 5 minutes of sequencing needed to accurately classify ALL.
Genomic Atlas Identifies Druggable Proteins for Neurological Disorders
In order to generate a genomic atlas of protein levels in neurologically relevant tissues, Dr. Carlos Cruchaga and his team profiled thousands of proteins, and performed bioinformatic analyses to determine if any of the identified proteins are drugable.
Exploring the Lipid Landscape and Unravelling Isomers
This webinar explores the use of high-resolution ion mobility performed on the MOBIE platform for the characterization of different lipid classes starting from phosphatidylcholines and gangliosides.
Mapping the Future of Psychedelics: Deconstructing Powerful Drugs To Make Better Medicine
Join us on June 22 with Boris Heifets, MD, PhD, Assistant Professor of the Department of Anesthesiology, Perioperative and Pain Medicine at Stanford University School of Medicine, who will explore the future of psychedelic medicine.
Genomic Tools for Psilocybe cubensis Propagation
Kevin McKernan, CSO at Medicinal Genomics will be joining us to discuss genetic variation in the Psilocybe cubensis synthesis pathway and the design of qPCR assays for simultaneous quantification of E. coli and Salmonella species contamination concurrent with Psilocybe cubensis species identification.